Zenabis Announces Extension of Unsecured Convertible Notes

VANCOUVER, BC, Oct. 19, 2020 /CNW/ – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) is pleased to announce that it has entered into definitive agreements (the “Note Amending Agreements“) with the holders (the “Noteholders“) of two of the unsecured convertible notes originally issued by Zenabis Investments Ltd. on October 17, 2018, as amended on January 3, 2019 (each, a “Note” andContinue reading “Zenabis Announces Extension of Unsecured Convertible Notes”

Zenabis Announces Closing of Public Offering of Units

– Zenabis Global Inc. (TSX: ZENA)(“Zenabis” or the “Company“) is pleased to announce the closing of the previously announced overnight marketed offering of units of Zenabis (“Units“), including the exercise in part of the over-allotment option (together, the “Offering“). Pursuant to the Offering, the Company sold 89,317,747 Units at a price of $0.085 per Unit for aggregate grossContinue reading “Zenabis Announces Closing of Public Offering of Units”

Zenabis Announces Overnight Marketed Public Offering of Units for Proceeds of Approximately 6 Million

 – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) is pleased to announce that it is commencing a “best efforts” overnight marketed offering of units (“Units“) of the Company (the “Offering“) for gross proceeds of approximately $6,000,000 with ATB Capital Markets Inc., as lead agent on behalf of a syndicate of agents to be formed (collectively, the “Agents“).Continue reading “Zenabis Announces Overnight Marketed Public Offering of Units for Proceeds of Approximately 6 Million”

Zenabis Provides Corporate Update

VANCOUVER, BC, Sept. 15, 2020 /CNW/ – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) today provided its monthly operational update for August, 2020.   Highlights Shai Altman assumed the role of Zenabis’ Chief Executive Officer on September 1, 2020. The Company shipped approximately 4,700 kg of cannabis in the first two months of the third quarter of 2020,Continue reading “Zenabis Provides Corporate Update”

Zenabis Announces First Shipment to Australia

Cannabis Shipment Volume Over First Two Months of Third Quarter ~20% Higher Than Cannabis Shipment Volume Over Entire Second Quarter – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) today announced that its first shipments to Australia from its Zenabis Atholville facility was completed on August 28, 2020. Zenabis has commenced the supply of packaged cannabis flower under aContinue reading “Zenabis Announces First Shipment to Australia”

Zenabis Global Inc. Enters Into a Purchase Agreement With MPX International’s Wholly-Owned Subsidary, Canveda Inc., for the Supply of Cannabis Flower

– Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company”) has announced entering into a one year supply agreement for high-quality cannabis flower with Canveda Inc. (“Canveda”), a wholly-owned subsidiary of MPX International Corporation (“MPX International”, or “MPXI”) ), a multinational diversified cannabis company. The supply agreement between the parties provides Canveda with a minimum of 300Continue reading “Zenabis Global Inc. Enters Into a Purchase Agreement With MPX International’s Wholly-Owned Subsidary, Canveda Inc., for the Supply of Cannabis Flower”

Zenabis Provides Corporate Update

VANCOUVER, BC, June 16, 2020 /CNW/ – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) today provided a corporate update on its recent activities. Highlights Zenabis Atholville has commenced cultivation of thirteen new high THC cultivars with commercial roll out of three of the new cultivars expected to occur in July with the remaining ones to be rolledContinue reading “Zenabis Provides Corporate Update”

Zenabis Files Amended and Restated Interim Financials and MD&A for Q1 2020

VANCOUVER, BC, June 13, 2020 /CNW/ – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) announces that following a review by the Company’s auditors, the Company has filed amended and restated interim financial statements and management’s discussion and analysis for the three months ended March 31, 2020 and 2019. Zenabis noted that while the changes discussed below result in aContinue reading “Zenabis Files Amended and Restated Interim Financials and MD&A for Q1 2020”

Zenabis Announces Term Sheet for the Supply of Medical Cannabis to the German Market and Receipt of a License Amendment for Zenabis Stellarton

Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) is pleased to announce that it has assigned its binding term sheet with Farmako GmbH (“Farmako”) to its subsidiary company ZenPharm for the supply of  European Union Good Manufacturing Practices (“EU GMP”) certified medicinal cannabis and amended the terms to provide for a minimum volume guarantee.  TheContinue reading “Zenabis Announces Term Sheet for the Supply of Medical Cannabis to the German Market and Receipt of a License Amendment for Zenabis Stellarton”